Product Code: GVR-2-68038-339-3
Clinical Decision Support Systems Market Growth & Trends:
The global clinical decision support systems market size is anticipated to reach USD 10.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 10.4% from 2022 to 2030. Surging demand for quality care is one of the primary factors augmenting the market. Constant lookout for reliable technology solutions by care providers is also expected to work in favor of the market. The growing interest in enhanced medical care and efficient decision-making is projected to fuel the adoption of clinical decision support systems (CDSS) and EHR.
To manage the COVID-19 pandemic, many initiatives are being undertaken by government and community organizations to support the current healthcare system. These comprise front-line clinics by state governments, volunteer panels of doctors, and many private telemedicine applications. CDSS is playing a vital role during the pandemic, by helping physicians make effective choices at the point of care. As a result, market players are capitalizing on this opportunity to address the problem and provide support to front-line doctors.
For instance, in May 2021, DHIndia announced a collaboration with EHRC@IIITB & Healthelife to develop CDSS for COVID-19 screening. This collaboration also included the formation of a minimal triage application for front-line clinicians.
Decision support in critical health situations proves to be significant. Furthermore, these systems analyze patient medical records and provide a list of possible solutions from which the most appropriate is to be selected. Easy compatibility and interoperability of systems with different platforms have enhanced the growth prospects of the market. Collaborative efforts of researchers and software developers to make medical knowledge available to users are anticipated to contribute to lucrative revenue generation during the forecast period.
CDSS is currently being used in a variety of healthcare operations, including diagnosis, drug prescription, and clinical studies. According to the NCBI in 2020, clinical and diagnostic coding, procedure and test ordering, and patient triage are all supported by CDSS. Developed algorithms can provide a refined list of diagnostic codes to help clinicians choose the most appropriate one. A CDSS was created to overcome the inaccuracy of ICD-9 admission coding in emergency departments (EDs) (ICD is the International Statistical Classification of Diseases, standardized codes used to represent diseases and diagnoses).
CDSS helps ED physicians to identify diagnostic admission codes more quickly. Furthermore, the significance of CDSS has been recognized across several healthcare entities, including public & private healthcare sectors. Also, healthcare organizations are launching programs to promote EHR & CDSS installation and integration, which is projected to have a favorable impact on the market by encouraging hospitals and healthcare groups to use such systems.
Clinical Decision Support Systems Market Report Highlights:
- Standalone CDSS accounted for the largest share of market revenue in 2021 owing to its low cost. The segment is estimated to hold approximately 30.0% of the overall market by 2030
- The CDSS integrated with EHR segment is poised to experience noteworthy growth in the coming years due to the rapid adoption of healthcare IT solutions by clinicians
- Drug allergy alerts made the highest contribution to market revenue generation in 2021 owing to the rising burden of allergies
- In terms of revenue, the on-premises segment dominated the overall industry with a share of over 43.0% in 2021, owing to its high adoption rate by healthcare organizations
- CDSS software segment is poised for lucrative growth during the forecast period owing to novel innovations for technical support and interoperability of the CDSS software
- Domicile of a large number of key players and high adoption rate of advanced technologies are anticipated to contribute to the dominance of the North American region in the coming years. However, Asia Pacific is estimated to witness the highest CAGR of 13.5% during the forecast period
- Market players are involved in strategic initiatives such as new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other
- For instance, in October 2021, DreaMed Diabetes AI Ltd. proclaimed that it had received FDA Clearance for its Type 2 Diabetes AI-based CDSS, thereby enhancing its offerings
Table of Contents
Chapter 1 Research Methodology & Scope
- 1.1 Market Segmentation & Scope
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary sources
- 1.3.4 Primary Research
- 1.3.5 Details of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.7 List Of Secondary Sources
- 1.8 Report Objectives
Chapter 2 Executive Summary
- 2.1 Clinical Decision Support Systems Market Outlook, 2017 - 2030 (USD Million)
- 2.2 Clinical Decision Support Systems Market Summary, 2020
Chapter 3 Clinical Decision Support Systems Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent market outlook
- 3.1.2 Ancillary market outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 Clinical Decision Support Systems Market Dynamics
- 3.3.1 Market driver analysis
- 3.3.1.1 Increase in demand for quality care and technical solutions
- 3.3.1.2 Rise in adoption of CDSS by organizations
- 3.3.1.3 Levels and impact of CDSS use
- 3.3.1.4 Government initiatives for adoption and implementation of health IT solutions
- 3.3.1.5 Rise in technological innovations
- 3.3.1.6 Increasing number of mergers & acquisitions by market players
- 3.3.1.7 Growing incidence of medication errors
- 3.3.2 Market restraint analysis
- 3.3.2.1 Expensive and time-consuming implementation
- 3.3.2.2 Lack of trained personnel
- 3.3.3 Market Opportunity Analysis
- 3.3.3.1 Government initiatives for better healthcare in developing countries
- 3.3.4 Market Threat Analysis
- 3.3.4.1 Data security concerns
- 3.4 Clinical Decision Support Systems Market Analysis Tools
- 3.4.1 Industry analysis - Porter's Five Forces
- 3.4.1.1 Bargaining Power of Suppliers: LOW
- 3.4.1.2 Bargaining Power of Buyers: moderate
- 3.4.1.3 Threat of Substitutes: moderate
- 3.4.1.4 Threat of New Entrants: moderate
- 3.4.1.5 Competitive Rivalry: High
- 3.4.2 Clinical Decision Support Systems- SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
- 3.4.2.1 Political & Legal
- 3.4.2.2 Economic
- 3.4.2.3 Technological
- 3.4.2.4 Social
- 3.5 Clinical Decision Support System - Unmet Need Analysis
Chapter 4 COVID-19 Impact Analysis
- 4.1 Impact of COVID-19
- 4.1.1 Disease Prevalence Analysis
- 4.2 Current and Future Impact Analysis
- 4.2.1 Current Impact Analysis
- 4.2.2 Future Impact Analysis
- 4.3 Impact on Market Players
Chapter 5 Clinical Decision Support Systems Market: Product Estimates & Trend Analysis
- 5.1 Product Market Share Analysis, 2021 & 2030
- 5.2 Product Dashboard
- 5.3 Standalone CDSS
- 5.3.1 Standalone CDSS market estimates and forecasts, 2017 - 2030 (USD Million)
- 5.4 Integrated CPOE With CDSS
- 5.4.1 Integrated CPOE with CDSS market estimates and forecasts, 2017 - 2030 (USD Million)
- 5.5 Integrated EHR With CDSS
- 5.5.1 Integrated EHR with CDSS market estimates and forecasts, 2017 - 2030 (USD Million)
- 5.6 Integrated CDSS With CPOE and EHR
- 5.6.1 Integrated CDSS with CPOE and EHR market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 6 Clinical Decision Support Systems Market: Application Estimates & Trend Analysis
- 6.1 Application Market Share Analysis, 2021 & 2030
- 6.2 Application Dashboard
- 6.3 Drug-Drug Interactions (DDI)
- 6.3.1 Drug-Drug Interactions (DDI) market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.4 Drug Allergy Alerts
- 6.4.1 Drug Allergy Alerts market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.5 Clinical Reminders
- 6.5.1 Clinical Reminders market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.6 Clinical Guidelines
- 6.6.1 Clinical Guidelines market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.7 Drug Dosing Support
- 6.7.1 Drug Dosing Support market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.8 Others
- 6.8.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7 Clinical Decision Support Systems Market: Delivery Mode Estimates & Trend Analysis
- 7.1 Delivery Mode Market Share Analysis, 2021 & 2030
- 7.2 Delivery Mode Dashboard
- 7.3 Web-Based Systems
- 7.3.1 Web-based CDSS market estimates and forecasts, 2017 - 2030 (USD Million)
- 7.4 Cloud-Based Systems
- 7.4.1 Cloud-based systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 7.5 On-Premises Systems
- 7.5.1 On-premises systems market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 8 Clinical Decision Support Systems Market: Component Estimates & Trend Analysis
- 8.1 Component Market Share Analysis, 2021 & 2030
- 8.2 Component Dashboard
- 8.3 Hardware
- 8.3.1 Hardware market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.4 Software
- 8.4.1 Software market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.5 Services
- 8.5.1 Services market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 9 Clinical Decision Support Systems Market: Regional Estimates & Trend Analysis, By Product, Application, Delivery Mode, and Component
- 9.1 Regional Market Snapshot
- 9.2 Region Market Share Analysis, 2021 & 2030
- 9.3 North America
- 9.3.1 North America Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.3.2 U.S.
- 9.3.2.1 U.S. Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.3.3 Canada
- 9.3.3.1 Canada Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.4 Europe
- 9.4.1 Europe Clinical Decision Support Systems MARKET estimates and forecasts, 2017 - 2030 (USD Million)
- 9.4.2 U.K.
- 9.4.2.1 U.K. Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.4.3 Germany
- 9.4.3.1 Germany Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.4.4 France
- 9.4.4.1 France Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.4.5 Italy
- 9.4.5.1 Italy Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.4.6 Spain
- 9.4.6.1 Spain Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.5 Asia Pacific
- 9.5.1 Asia Pacific Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.5.2 Japan
- 9.5.2.1 Japan Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.5.3 China
- 9.5.3.1 China Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.5.4 India
- 9.5.4.1 India Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.5.5 Australia
- 9.5.5.1 Australia Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.5.6 South Korea
- 9.5.6.1 South Korea Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.6 Latin America
- 9.6.1 Latin America Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.6.2 Mexico
- 9.6.2.1 Mexico Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.6.3 Brazil
- 9.6.3.1 Brazil Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.6.4 Argentina
- 9.6.4.1 Argentina Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.7 Middle East & Africa (MEA)
- 9.7.1 MEA Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.7.2 South Africa
- 9.7.2.1 South Africa Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.7.3 Saudi Arabia
- 9.7.3.1 Saudi Arabia Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.7.4 Israel
- 9.7.4.1 Israel Clinical Decision Support Systems market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 10 Company Profiles
- 10.1 Company Profiles
- 10.1.1 McKesson Corporation
- 10.1.1.1 Company overview
- 10.1.1.2 Financial performance
- 10.1.1.3 Product benchmarking
- 10.1.1.4 Strategic initiatives
- 10.1.2 Cerner Corporation
- 10.1.2.1 Company overview
- 10.1.2.2 Financial performance
- 10.1.2.3 Product benchmarking
- 10.1.2.4 Strategic initiatives
- 10.1.3 Siemens Healthcare GmbH
- 10.1.3.1 Company overview
- 10.1.3.2 Financial performance
- 10.1.3.3 Product benchmarking
- 10.1.3.4 Strategic initiatives
- 10.1.4 Allscripts Healthcare, LLC
- 10.1.4.1 Company overview
- 10.1.4.2 Financial performance
- 10.1.4.3 Product benchmarking
- 10.1.4.4 Strategic initiatives
- 10.1.5 athenahealth, Inc.
- 10.1.5.1 Company overview
- 10.1.5.2 Financial performance
- 10.1.5.3 Product benchmarking
- 10.1.5.4 Strategic initiatives
- 10.1.6 NextGen Healthcare, Inc.
- 10.1.6.1 Company overview
- 10.1.6.2 Financial performance
- 10.1.6.3 Product benchmarking
- 10.1.6.4 Strategic initiatives
- 10.1.7 Koninklijke Philips N.V.
- 10.1.7.1 Company overview
- 10.1.7.1 Financial performance
- 10.1.7.2 Product benchmarking
- 10.1.7.3 Strategic initiatives
- 10.1.8 IBM Corporation
- 10.1.8.1 Company overview
- 10.1.8.2 Financial performance
- 10.1.8.3 Research, development and engineering expenditure
- 10.1.8.4 Product benchmarking
- 10.1.8.5 Strategic initiatives
- 10.1.9 Agfa-Gevaert Group
- 10.1.9.1 Company overview
- 10.1.9.2 Financial performance
- 10.1.9.3 Product benchmarking
- 10.1.9.4 Strategic initiatives
- 10.1.10 Wolters Kluwer N.V.
- 10.1.10.1 Company overview
- 10.1.10.2 Financial performance
- 10.1.10.3 Product benchmarking
- 10.1.10.4 Strategic initiatives
- 10.2 Market Participation Categorization
- 10.3 Company Dashboard Analysis
- 10.4 Public Companies
- 10.4.1 Company market position analysis
- 10.4.2 Synergy Analysis: Major Deals & Strategic Alliances
- 10.5 Detailed List of Market Players
- 10.6 Key Players Comparison Table - Clinical Decision Support System Market